Fredun Pharmaceuticals Limited (FREDUN.BO)
INR 694.65
(1.89%)
INR 694.65
(1.89%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 360.45 Million INR | -27.31% |
| 2022 | 299.43 Million INR | 21.64% |
| 2021 | 246.16 Million INR | 45.22% |
| 2020 | 169.51 Million INR | -11.55% |
| 2019 | 191.65 Million INR | -14.34% |
| 2018 | 223.73 Million INR | 75.61% |
| 2017 | 127.4 Million INR | 6.3% |
| 2016 | 119.85 Million INR | 35.31% |
| 2015 | 88.57 Million INR | 29.83% |
| 2014 | 68.22 Million INR | 72.74% |
| 2013 | 39.49 Million INR | -1.5% |
| 2012 | 40.09 Million INR | 52.34% |
| 2011 | 26.32 Million INR | -30.87% |
| 2010 | 38.07 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 43.99 Million INR | -50.73% |
| 2023 FY | 217.65 Million INR | -27.31% |
| 2023 Q4 | 89.29 Million INR | 34.17% |
| 2023 Q3 | 66.54 Million INR | 0.09% |
| 2023 Q2 | 66.48 Million INR | -6.47% |
| 2023 Q1 | 71.08 Million INR | -68.81% |
| 2022 FY | 299.43 Million INR | 21.64% |
| 2022 Q4 | 227.91 Million INR | 218.68% |
| 2022 Q2 | 58.93 Million INR | 2.57% |
| 2022 Q1 | 57.46 Million INR | -33.27% |
| 2022 Q3 | 71.51 Million INR | 21.34% |
| 2021 Q1 | 45.14 Million INR | -24.85% |
| 2021 FY | 246.16 Million INR | 45.22% |
| 2021 Q4 | 86.11 Million INR | 28.23% |
| 2021 Q3 | 67.15 Million INR | 20.44% |
| 2021 Q2 | 55.75 Million INR | 23.5% |
| 2020 Q4 | 60.07 Million INR | 44.54% |
| 2020 Q1 | 27.72 Million INR | -58.65% |
| 2020 FY | 169.51 Million INR | -11.55% |
| 2020 Q2 | 38.46 Million INR | 38.73% |
| 2020 Q3 | 41.56 Million INR | 8.07% |
| 2019 Q1 | 39.35 Million INR | -31.75% |
| 2019 FY | 191.65 Million INR | -14.34% |
| 2019 Q2 | 28.61 Million INR | -27.3% |
| 2019 Q3 | 49.08 Million INR | 71.52% |
| 2019 Q4 | 67.03 Million INR | 36.58% |
| 2018 Q4 | 57.66 Million INR | 5.85% |
| 2018 FY | 223.73 Million INR | 75.61% |
| 2018 Q3 | 54.47 Million INR | -10.1% |
| 2018 Q2 | 60.59 Million INR | 27.46% |
| 2018 Q1 | 47.54 Million INR | -6.69% |
| 2017 FY | 127.4 Million INR | 6.3% |
| 2017 Q1 | 26.39 Million INR | -46.74% |
| 2017 Q2 | 34.79 Million INR | 31.82% |
| 2017 Q3 | 35.86 Million INR | 3.09% |
| 2017 Q4 | 50.95 Million INR | 42.07% |
| 2016 FY | 119.85 Million INR | 35.31% |
| 2016 Q3 | 33.48 Million INR | -15.81% |
| 2016 Q2 | 39.77 Million INR | 32.36% |
| 2016 Q1 | 30.04 Million INR | -32.51% |
| 2016 Q4 | 49.55 Million INR | 48.0% |
| 2015 Q1 | 21.57 Million INR | 340.06% |
| 2015 FY | 88.57 Million INR | 29.83% |
| 2015 Q4 | 44.52 Million INR | 58.43% |
| 2015 Q3 | 28.1 Million INR | 33.31% |
| 2015 Q2 | 21.08 Million INR | -2.27% |
| 2014 Q2 | 24.6 Million INR | 45.4% |
| 2014 Q1 | 16.92 Million INR | 240.16% |
| 2014 FY | 68.22 Million INR | 72.74% |
| 2014 Q4 | -8.98 Million INR | -170.93% |
| 2014 Q3 | 12.66 Million INR | -48.51% |
| 2013 Q1 | 15.12 Million INR | 175.43% |
| 2013 FY | 39.49 Million INR | -1.5% |
| 2013 Q3 | 22.07 Million INR | -29.21% |
| 2013 Q2 | 31.19 Million INR | 106.28% |
| 2013 Q4 | -12.07 Million INR | -154.69% |
| 2012 Q4 | -20.04 Million INR | -170.55% |
| 2012 FY | 40.09 Million INR | 52.34% |
| 2012 Q3 | 28.41 Million INR | 86.14% |
| 2012 Q2 | 15.26 Million INR | 2.76% |
| 2012 Q1 | 14.85 Million INR | 0.0% |
| 2011 FY | 26.32 Million INR | -30.87% |
| 2010 FY | 38.07 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| ANG Lifesciences India Limited | 219.92 Million INR | -63.898% |
| DECIPHER LABS LIMITED | 277.6 Million INR | -29.848% |
| Ishita Drugs and Industries Limited | 16.46 Million INR | -2088.972% |
| Jenburkt Pharmaceuticals Limited | 437.2 Million INR | 17.554% |
| Patidar Buildcon Limited | 1.81 Million INR | -19803.81% |
| Sanjivani Paranteral Limited. | 208.87 Million INR | -72.569% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.52 Million INR | -23552.1% |
| Source Natural Foods and Herbal Supplements Limited | 31.85 Million INR | -1031.488% |
| Sunil Healthcare Limited | 438.1 Million INR | 17.724% |
| MedPlus Health Services Limited | 2.42 Billion INR | 85.13% |
| KIMIA BIOSCIENCES LIMITED | 149.52 Million INR | -141.075% |
| Add-Shop E-Retail Limited | 146.52 Million INR | -146.003% |
| Bacil Pharma Limited | 1.87 Million INR | -19130.683% |
| BDH Industries Limited | 57.03 Million INR | -532.028% |
| Beryl Drugs Limited | 93.77 Million INR | -284.402% |
| Cian Healthcare Limited | 59.19 Million INR | -508.892% |
| Concord Drugs Limited | 91.83 Million INR | -292.519% |
| Deccan Health Care Limited | 36.24 Million INR | -894.586% |
| Gujarat Terce Laboratories Limited | 132.41 Million INR | -172.21% |
| Gujarat Themis Biosyn Limited | 156.84 Million INR | -129.815% |
| Medi-Caps Limited | 93.11 Million INR | -287.098% |
| Parmax Pharma Limited | 99.31 Million INR | -262.936% |
| Sastasundar Ventures Limited | 846.78 Million INR | 57.432% |
| Smruthi Organics Limited | 261.73 Million INR | -37.719% |
| SUDARSHAN PHARMA INDUSTRIES LI | 146.09 Million INR | -146.735% |
| Phaarmasia Limited | 50.52 Million INR | -613.411% |
| Syschem (India) Limited | 64.13 Million INR | -462.056% |
| Transchem Limited | 8.47 Million INR | -4154.196% |
| Trinity League India Limited | -1.08 Million INR | 33291.344% |
| Tyche Industries Limited | 182.04 Million INR | -98.008% |
| Vista Pharmaceuticals Limited | 20.16 Million INR | -1687.454% |
| Zenith Healthcare Limited | 45.97 Million INR | -683.979% |
| Chemo Pharma Laboratories Limited | 1.94 Million INR | -18413.508% |
| Colinz Laboratories Limited | 31.19 Million INR | -1055.388% |
| Denis Chem Lab Limited | 453.36 Million INR | 20.493% |
| Hindustan Bio Sciences Limited | 2.6 Million INR | -13718.9% |
| Kwality Pharmaceuticals Limited | 248.93 Million INR | -44.802% |
| Makers Laboratories Limited | 83.1 Million INR | -333.743% |
| Panchsheel Organics Limited | 68.15 Million INR | -428.849% |
| Parnax Lab Limited | 80.59 Million INR | -347.263% |
| PRAVEG LIMITED | 77.18 Million INR | -367.023% |
| Mercury Laboratories Limited | 217.24 Million INR | -65.925% |
| Trident Lifeline Limited | 46.87 Million INR | -669.043% |
| Vikram Thermo (India) Limited | 104.27 Million INR | -245.677% |
| Vivanza Biosciences Limited | 4.55 Million INR | -7813.458% |
| Zenlabs Ethica Limited | 57.89 Million INR | -522.606% |
| SHELTER PHARMA LIMITED | 12.3 Million INR | -2830.434% |
| Vasundhara Rasayans Limited | 145.5 Million INR | -147.726% |
| Bharat Immunologicals & Biologicals Corporation Limited | 184.08 Million INR | -95.814% |
| Roopa Industries Limited | 24.63 Million INR | -1363.195% |
| PANJON LTD. | 33.77 Million INR | -967.107% |
| Pharmaids Pharmaceuticals Limited | 76.49 Million INR | -371.224% |
| TIAAN CONSUMER LIMITED | 107 Thousand INR | -336776.636% |
| Anuh Pharma Limited | 263.04 Million INR | -37.033% |
| Crestchem Limited | 50.8 Million INR | -609.527% |
| Emmessar Biotech & Nutrition Limited | 4.32 Million INR | -8240.074% |
| Sandu Pharmaceuticals Limited | 212.9 Million INR | -69.308% |
| Trimurthi Limited | 4.81 Million INR | -7392.372% |
| Shukra Pharmaceuticals Limited | 83.05 Million INR | -334.01% |
| Norris Medicines Limited | 18.2 Million INR | -1879.978% |
| Veerhealth Care Limited | 15.38 Million INR | -2243.375% |
| Lactose (India) Limited | 111.66 Million INR | -222.812% |
| OXYGENTA PHARMACEUTICAL LIMITE | 23.78 Million INR | -1415.803% |
| Ambalal Sarabhai Enterprises Limited | 280.83 Million INR | -28.354% |
| Gennex Laboratories Limited | 130.37 Million INR | -176.474% |
| Godavari Drugs Limited | 359.01 Million INR | -0.403% |
| Zenotech Laboratories Limited | 94.82 Million INR | -280.142% |
| Shree Ganesh Remedies Limited | 104.13 Million INR | -246.145% |
| Bharat Parenterals Limited | 255.97 Million INR | -40.816% |
| Coral Laboratories Limited | 189.75 Million INR | -89.956% |
| Evoq Remedies Limited | 4.51 Million INR | -7880.031% |
| Kerala Ayurveda Limited | 399.64 Million INR | 9.805% |
| KOBO BIOTECH LIMITED | 2.48 Million INR | -14434.597% |
| Natural Capsules Limited | 444.7 Million INR | 18.944% |
| Auro Laboratories Limited | 157.37 Million INR | -129.043% |